| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71d28ab608e3442381a42067467e3aa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14b7078e5423021d83cf4a8627e4cd1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a647b476162f34430678d9af1920181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e5721ddd3eaa090308244bf3ec6a72d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f9f942e268912b28c16b19a1354fa74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14b3ac6d6b481346179cfb48da6bfaa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_228f89bbfe2d9a0a547a91c216c6c6c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ced543226d8f0a473ed5069549bd8458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f1bc9936228e23253e52baaddcb4a4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5e99b688e51043a7d6e5412db3e6dcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db385f414a96368dac6362b878c8ee37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eff6e51a621e33ce891c84f7c2b9a492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f08cf1a9fa4cb2defbe118da3962d0a |
| publicationDate |
2020-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020101038-A1 |
| titleOfInvention |
Altertoxin ii as a selective inhibitor of ewing family of tumor cells |
| abstract |
Certain embodiments are directed to methods for treating Ewing family tumors (EFT) comprising administering an effective amount of altertoxin II to a subject having EFT. |
| priorityDate |
2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |